Mucormycosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 30: | Line 30: | ||
==Prognosis== | ==Prognosis== | ||
Mortality 30-90% | Mortality 30-90% | ||
==See Also== | |||
*[[Fungal Infections]] | |||
[[Category:ID]] | [[Category:ID]] | ||
Revision as of 00:12, 18 April 2014
Background
- Infection of fungal hyphae in immunocompromised hosts
- DM
- HIV
- Neutropenic
Locations
- Most commonly affects paranasal sinuses (rhinocerebral mucormycosis)
- Pulmonary
- GI
- CNS
Diagnosis
Rhinocerebral: mimics acute bacterial sinusitis, however a much more rapid, extensive expansion of the fungus to the surrounding anatomy is classic
Can spread to orbits, oropharynx, nasopharynx, brain, nearby vasculature leading to:
- Vision changes
- Nasopharyngeal and oropharyngeal ulceration or eschars
- Facial edema, pain
- Cranial nerve deficits
- Headache
Workup
CT scan of sinuses
Treatment
- Adjunctive: Amphotericin B (1mgkg/d IV)
- Definitive: Prompt surgical consultation --> debridement
Prognosis
Mortality 30-90%
